Given that SP1 elevates ETBR levels and exacerbates cerebral ischemia, relevant studies have confirmed that mithramycin A can be used to reduce ETBR expression on cerebral arterial smooth muscle after I/R (Grell et al., 2014). This evidence concerns the gene SP1 and brain ischemia.